Xiphora Biopharma Consulting is a UK-
consultancy offering nonclinical services to the
The principal, David Snodin, PhD, is a regulatory pharmacotoxicologist with over
30 years’ experience in industry, government and consulting.
As well as general nonclinical consulting, we specialize in dealing with issues at
the Quality-Safety interface, particularly impurity qualification and the safety
assessment of excipients.
Our services include Nonclinical Drug Development and Specialist Consulting.
For more information please select Services from the menu above.